1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pearls and pitfalls of genomics-based microbiome analysis
    Journal Article

    Carlos, N.; Tang, Y. W.; Pei, Z.
    Emerging Microbes & Infections (2012)

    Fulltext@MSK | Save
  • Framing and dosage effects: Use of protection motivation theory to examine efficacy of anti-cocaine visual messages
    Journal Article

    Banerjee, S. C.; Greene, K.
    International Journal of Health Promotion and Education (2012)

    Fulltext@MSK | Save
  • Actomyosin-based Self-organization of cell internalization during C. elegans gastrulation
    Journal Article

    Pohl, C.; Tiongson, M.; Moore, J. L.; Santella, A.; Bao, Z.
    BMC Biology (2012)

    Fulltext@MSK | Save
  • CMX001 is an effective treatment option for refractory CMV infection or disease in HCT recipients: A single center's experience
    Meeting Abstract

    Papanicolaou, G.; Mommeja-Marin, H.; Anderson, M.; Godkin, S.; Chittick, G.; Painter, W.
    Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (2012)

    Fulltext@MSK | Save
  • BK Polyomavirus (BKV) IgG Is A Predictor Of High Level BKV Viruria After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
    Meeting Abstract

    Lee, Y. J.; Chung, D.; Figueroa, C.; Amigues, I.; Son, T.; Hester, J.; Jakubowski, A.; Papanicolaou, G.
    Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (2012)

    Fulltext@MSK | Save
  • Comparison of Surveillance Culture to Xpert (R) vanA Assay for detection of Vancomycin-resistant Enterococci
    Meeting Abstract

    Gilhuley, K.; Cianciminio Bordelon, D.; Reid, D.; Tulumba, S.; Tang, Y.; Babady, N. E.
    Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (2012)

    Fulltext@MSK | Save
  • Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Ryan, C. J.; Smith, M. R.; de Bono, J. S.; Molina, A.; Logothetis, C.; De Souza, P. L.; Fizazi, K.; Mainwaring, P. N.; Rodriguez, J. M. P.; Ng, S.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • CALGB 40502/NCCTG N063H: Randomized phase III trial of weekly paclitaxel (P) compared to weekly nanoparticle albumin bound nab-paclitaxel (NP) or ixabepilone (Ix) with or without bevacizumab (B) as first-line therapy for locally recurrent or metastatic breast cancer (MBC)
    Meeting Abstract

    Rugo, H. S.; Barry, W. T.; Moreno-Aspitia, A.; Lyss, A. P.; Cirrincione, C.; Mayer, E. L.; Naughton, M.; Layman, R. M.; Carey, L. A.; Somer, R. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • New insights into the risk of breast cancer in childhood cancer survivors treated with chest radiation: A report from the Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study
    Meeting Abstract

    Moskowitz, C. S.; Chou, J. F.; Wolden, S. L.; Bernstein, J. L.; Malhotra, J.; Friedman, D. N.; Mubdi, N. Z.; Henderson, T. O.; Leisenring, W. M.; Stovall, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase III, randomized, open-label, multicenter trial (BREAK-3) comparing the BRAF kinase inhibitor dabrafenib (GSK2118436) with dacarbazine (DTIC) in patients with BRAF(V600E)-mutated melanoma
    Meeting Abstract

    Hauschild, A.; Grob, J. J.; Demidov, L. V.; Jouary, T.; Gutzmer, R.; Millward, M.; Rutkowski, P.; Blank, C. U.; Mirakhur, B.; Guckert, M. E.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save